Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma

Abstract

Compared to PL, HPL was associated with a significantly better treatment response and survival benefits for patients with advanced HCC.